Monoclonal gammopathy of undetermined significance screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
There is no role of screening in patients for monoclonal gammopathy of undetermined significance.
Screening
Screening
There is no role of screening in patients for monoclonal gammopathy of undetermined significance.[1]
References
References
- ↑ Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (July 2010). “Monoclonal gammopathy of undetermined significance: a consensus statement”. Br. J. Haematol. 150 (1): 28–38. doi:10.1111/j.1365-2141.2010.08207.x. PMID 20507313.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH